The DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Obesity, metabolic syndrome, and prostate cancer
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
Obesity and the role of adipose tissue in inflammation and metabolism
Greenberg, A. S., & Obin, M. S. (2006) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/83.2.461s · Cited by 1,273
Dandona, P., Aljada, A., Chaudhuri, A., Mohanty, P., & Garg, R. (2005) · Circulation · doi:10.1161/01.cir.0000158483.13093.9d · Cited by 1,263
Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses
Sha, W. C., Liou, H.-C., Tuomanen, E. I., & Baltimore, D. (1995) · Cell · doi:10.1016/0092-8674(95)90415-8 · Cited by 1,157
International trends and patterns of prostate cancer incidence and mortality
Hsing, A. W., Tsao, L., & Devesa, S. S. (2000) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(20000101)85:1<60::aid-ijc11>3.0.co;2-b · Cited by 846
Self-citationKupelian, V., Page, S. T., Araujo, A. B., Travison, T. G., Bremner, W. J., & McKinlay, J. B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1326 · Cited by 561
Pathological and molecular aspects of prostate cancer
DeMarzo, A. M., Nelson, W. G., Isaacs, W. B., & Epstein, J. I. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12779-1 · Cited by 472
Hsing, A. (2006) · Frontiers in Bioscience · doi:10.2741/1891 · Cited by 447
Self-citationInsulin resistance as the core defect in type 2 diabetes mellitus
Goldstein, B. J. (2002) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)02553-5 · Cited by 432 · cited 2×
“The lower prostate cancer risk associated with long-term diabetes has been attributed, in part, to the lower serum concentrations of insulin and testosterone among men with diabetes (67).”
BackgroundBody size and composition and prostate cancer risk: systematic review and meta-regression analysis
MacInnis, R. J., & English, D. R. (2006) · Cancer Causes & Control · doi:10.1007/s10552-006-0049-z · Cited by 411
THE ROLE OF INFLAMMATION IN THE PATHOGENESIS OF PROSTATE CANCER
NELSON, W. G., DE MARZO, A. M., DeWEESE, T. L., & ISAACS, W. B. (2004) · Journal of Urology · doi:10.1097/01.ju.0000142058.99614.ff · Cited by 386
Rodriguez, C., Freedland, S. J., Deka, A., Jacobs, E. J., McCullough, M. L., Patel, A. V., Thun, M. J., & Calle, E. E. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0754 · Cited by 354
Rodríguez, C., Patel, A. V., Calle, E. E., Jacobs, E. J., Chao, A., & Thun, M. J. (2001) · PubMed · Cited by 354
Obesity, Diabetes, and Risk of Prostate Cancer: Results from the Prostate Cancer Prevention Trial
Gong, Z., Neuhouser, M. L., Goodman, P. J., Albanes, D., Chi, C., Hsing, A. W., Lippman, S. M., Platz, E. A., Pollak, M. N., Thompson, I. M., et al. (2006) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0477 · Cited by 352
Self-citationWright, M. E., Chang, S., Schatzkin, A., Albanes, D., Kipnis, V., Mouw, T., Hurwitz, P., Hollenbeck, A., & Leitzmann, M. F. (2007) · Cancer · doi:10.1002/cncr.22443 · Cited by 336
Diabetes mellitus and risk of prostate cancer: a meta-analysis
Bonovas, S., Filioussi, K., & Tsantes, A. (2004) · Diabetologia · doi:10.1007/s00125-004-1415-6 · Cited by 327
Changing demography of prostate cancer in Asia
Sim, H. G., & Cheng, C. W. S. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.033 · Cited by 319
Prostate Cancer Risk and Serum Levels of Insulin and Leptin: a Population-Based Study
Hsing, A. W., Chua, S., Gao, Y.-T., Gentzschein, E., Chang, L., Deng, J., & Stanczyk, F. Z. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.10.783 · Cited by 298
Self-citationTrends and Patterns of Prostate Cancer: What Do They Suggest?
Hsing, A. W., & Devesa, S. S. (2001) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a000792 · Cited by 292
Self-citationBody mass index and risk of prostate cancer in U.S. health professionals
Giovannucci, E., Rimm, E. B., Liu, Y., Leitzmann, M., Wu, K., Stampfer, M. J., & Willett, W. C. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djg009 · Cited by 258
Platz, E. A., Leitzmann, M. F., Rifai, N., Kantoff, P. W., Chen, Y.-C., Stampfer, M. J., Willett, W. C., & Giovannucci, E. (2005) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-04-0371 · Cited by 245
Epidemiology of Inflammation and Prostate Cancer
PLATZ, E. A., & De MARZO, A. M. (2004) · Journal of Urology · doi:10.1097/01.ju.0000108131.43160.77 · Cited by 243
Insulin Resistance and Prostate Cancer Risk
Hsing, A. W., Gao, Y.-T., Chua, S., Deng, J., & Stanczyk, F. Z. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.1.67 · Cited by 242
Self-citationHeight, body mass index, and prostate cancer: a follow-up of 950 000 Norwegian men
Engeland, A., Tretli, S., & Bjørge, T. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601206 · Cited by 217
Hormones and prostate cancer: Current perspectives and future directions
Hsing, A. W., Reichardt, J. K. V., & Stanczyk, F. Z. (2002) · The Prostate · doi:10.1002/pros.10108 · Cited by 208
Self-citationLeptin Is Associated with Increased Prostate Cancer Risk: A Nested Case-Referent Study1
Stattin, P., Söderberg, S., Hallmans, G., Bylund, A., Kaaks, R., Stenman, U.-H., Bergh, A., & Olsson, T. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.3.7328 · Cited by 196
Metabolic Syndrome and the Risk of Prostate Cancer in Finnish Men: A Population-Based Study
Laukkanen, J. A., Laaksonen, D. E., Niskanen, L., Pukkala, E., Hakkarainen, A., & Salonen, J. T. (2004) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.1646.13.10 · Cited by 189
Diabetes and Risk of Prostate Cancer in a Prospective Cohort of US Men
Rodriguez, C. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwh334 · Cited by 184
Visceral Fat Accumulation as a Risk Factor for Prostate Cancer
HAFE, P. V., Pina, F., Pérez, A., Tavares, M., & Barros, H. (2004) · Obesity Research · doi:10.1038/oby.2004.242 · Cited by 167
Lund Håheim, L., Wisløff, T. F., Holme, I., & Nafstad, P. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj284 · Cited by 165
The Metabolic Syndrome Is Associated with Reduced Risk of Prostate Cancer
Tande, A. J., Platz, E. A., & Folsom, A. R. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj320 · Cited by 163
Body size and prostate cancer: a population-based case-control study in China.
Hsing, A. W., Deng, J., Sesterhenn, I. A., Mostofi, F. K., Stanczyk, F. Z., Bénichou, J., Xie, T., & Gao, Y.-T. (2000) · PubMed · Cited by 159
Self-citationLeptin Influences Cellular Differentiation And Progression In Prostrate Cancer
Sağlam, K., Aydur, E., Yılmaz, M. İ., & Göktaş, S. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000055903.18400.25 · Cited by 156
Molecular Pathways to Prostate Cancer
Gonzalgo, M. L., & Isaacs, W. B. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000085381.20139.b6 · Cited by 153
Hammarsten, J., & Högstedt, B. (2004) · Blood Pressure · doi:10.1080/08037050310025735 · Cited by 146
Leptin Is Associated with Increased Prostate Cancer Risk: A Nested Case-Referent Study
Stattin, P. E. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.3.1341 · Cited by 142
Lessard, L., Bégin, L. R., Gleave, M. E., Mes‐Masson, A., & Fred Saad, C. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602796 · Cited by 140
Obesity and the risk of prostate cancer
Porter, M. P., & Stanford, J. L. (2004) · The Prostate · doi:10.1002/pros.20121 · Cited by 135
Obesity, Adipokines, and Prostate Cancer in a Prospective Population-Based Study
Baillargeon, J., Platz, E. A., Rose, D. P., Pollock, B. H., Ankerst, D. P., Haffner, S. M., Higgins, B., Lokshin, A. E., Troyer, D. A., Hernández, J., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0082 · Cited by 134
Fradet, V., Lessard, L., Bégin, L. R., Karakiewicz, P. I., Mes‐Masson, A., & Fred Saad, C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0764 · Cited by 131
Domenech, J. M. D., Mellado, B., Ferrer, B., Truan, D., Codony‐Servat, J., Sauleda, S., Alcover, J., Campo, E., Gascon, P., Rovira, A., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602851 · Cited by 116
Jonsson, F., Wolk, A., Pedersen, N. L., Lichtenstein, P., Terry, P., Ahlbom, A., & Feychting, M. (2003) · International Journal of Cancer · doi:10.1002/ijc.11266 · Cited by 116
Rising prostate cancer rates in South Korea
Park, S. K., Sakoda, L. C., Kang, D., Chokkalingam, A. P., Lee, E., Shin, H., Ahn, Y., Shin, M., Lee, C.-W., Lee, D., et al. (2006) · The Prostate · doi:10.1002/pros.20419 · Cited by 116
Self-citationBody size and composition and prostate cancer risk.
MacInnis, R. J., English, D. R., Gertig, D. M., Hopper, J. L., & Giles, G. G. (2003) · PubMed · Cited by 114
Ribeiro, R. J. T., Vasconcelos, A., Costa, S., Pinto, D., Morais, A., Oliveira, J., Lobo, F., Lopes, C., & Medeiros, R. (2003) · The Prostate · doi:10.1002/pros.20004 · Cited by 110
Lee, I.-M. M., Sesso, H. D., & Paffenbarger, R. S. (2001) · Cancer Causes & Control · doi:10.1023/a:1008952528771 · Cited by 105
Plasma androgens, IGF-1, body size, and prostate cancer risk: a synthetic review
Kaaks, R., Lukanova, A., & Sommersberg, B. (2000) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500421 · Cited by 105
Features of the metabolic syndrome and prostate cancer in African‐American men
Beebe‐Dimmer, J., Dunn, R. L., Sarma, A. V., Montie, J. E., & Cooney, K. A. (2007) · Cancer · doi:10.1002/cncr.22461 · Cited by 99
Case‐control study of anthropometric measures and prostate cancer risk
Friedenreich, C. M., McGregor, S. E., Courneya, K. S., Angyalfi, S. J., & Elliott, F. G. (2004) · International Journal of Cancer · doi:10.1002/ijc.20110 · Cited by 99
Nomura, A. M. Y. (2001) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a000777 · Cited by 99
Hubbard, J. S., Rohrmann, S., Landis, P., Metter, E. J., Muller, D. C., Andres, R., Carter, H. B., & Platz, E. A. (2004) · Urology · doi:10.1016/j.urology.2003.09.060 · Cited by 91
Early growth, adult body size and prostate cancer risk
Giles, G. G., Severi, G., English, D. R., McCredie, M. R. E., MacInnis, R. J., Boyle, P., & Hopper, J. L. (2002) · International Journal of Cancer · doi:10.1002/ijc.10810 · Cited by 88
Kaaks, R., Lukanova, A., Rinaldi, S., Biessy, C., Söderberg, S., Olsson, T., Stenman, U.-H., Ríboli, E., Hallmans, G., & Stattin, P. (2003) · European Journal of Cancer Prevention · doi:10.1097/00008469-200308000-00011 · Cited by 85
Body mass index in young adulthood and cancer mortality: a retrospective cohort study
Okasha, M., McCarron, P., McEwen, J., & Smith, G. D. (2002) · Journal of Epidemiology & Community Health · doi:10.1136/jech.56.10.780 · Cited by 77
Height, predictors of C-peptide and cancer risk in men
Giovannucci, E. L., Rimm, E. B., Liu, Y., & Willett, W. C. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh020 · Cited by 66
History of Diabetes Mellitus and Risk of Prostate Cancer in Physicians
Zhu, K., Lee, I.-M., Sesso, H. D., Buring, J. E., Levine, R. S., & Gaziano, J. M. (2004) · American Journal of Epidemiology · doi:10.1093/aje/kwh139 · Cited by 62
Interaction of Factors Related to the Metabolic Syndrome and Vitamin D on Risk of Prostate Cancer
Tuohimaa, P., Tenkanen, L., Syvälä, H., Lumme, S., Hakulinen, T. R., Dillner, J., & Hakama, M. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0777 · Cited by 62
Chan, J. M., Latini, D. M., Cowan, J. E., DuChane, J., & Carroll, P. R. (2005) · Cancer Causes & Control · doi:10.1007/s10552-005-3301-z · Cited by 62
Medical History and Etiology of Prostate Cancer
Giovannucci, E. L. (2001) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a000783 · Cited by 60
Interleukin-1 receptor antagonist haplotype associated with prostate cancer risk
Lindmark, F., Zheng, S. L., Wiklund, F., Bälter, K. A., Sun, J. Y., Chang, B., Hedelin, M., Clark, J., Johansson, J.-E., Meyers, D. A., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602729 · Cited by 59
Prostate cancer and body size at different ages: an Italian multicentre case–control study
Maso, L. D., Zucchetto, A., Vecchia, C. L., Montella, M., Conti, E., Canzonieri, V., Talamini, R., Tavani, A., Negri, E., Garbeglio, A., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601859 · Cited by 56
Insulin resistance: from benign to type 2 diabetes mellitus.
Goldstein, B. J. (2003) · PubMed · Cited by 54
Neuhausen, S. L., Slattery, M. L., Garner, C. P., Ding, Y. C., Hoffman, M. D., & Brothman, A. R. (2005) · The Prostate · doi:10.1002/pros.20216 · Cited by 53
Polymorphism of the insulin gene is associated with increased prostate cancer risk
Ho, G., Melman, A., Liu, S. M., Li, M., Yu, H., Negassa, A., Burk, R. D., Hsing, A. W., Ghavamian, R., & Chua, S. C. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600747 · Cited by 52
Self-citationObesity before Age 30 Years and Risk of Advanced Prostate Cancer
Robinson, W. R., Stevens, J., Gammon, M. D., & John, E. M. (2005) · American Journal of Epidemiology · doi:10.1093/aje/kwi150 · Cited by 51
Prostate Cancer Risk Among Men with Diabetes Mellitus (Spain)
González‐Pérez, A., & Rodríguez, L. A. G. (2005) · Cancer Causes & Control · doi:10.1007/s10552-005-4705-5 · Cited by 50
Gapstur, S. M., Kopp, P. A., Gann, P. H., Chiu, B. C. ‐., Colangelo, L. A., & Liu, K. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803465 · Cited by 48
Diabetes mellitus and prostate cancer risk among older men: population-based case–control study
Coker, A. L., Sanderson, M., Zheng, W., & Fadden, M. K. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601857 · Cited by 48
Obesity and the risk of prostate cancer (United States)
Bradbury, B. D., Wilk, J. B., & Kaye, J. A. (2005) · Cancer Causes & Control · doi:10.1007/s10552-005-0383-6 · Cited by 43
Diabetes Mellitus and the Risk of Prostate Cancer in Italy
Tavani, A., Gallus, S., Bertuzzi, M., Maso, L. D., Zucchetto, A., Negri, E., Franceschi, S., Ramazzotti, V., Montella, M., & Vecchia, C. L. (2004) · European Urology · doi:10.1016/j.eururo.2004.10.027 · Cited by 38
Association between leptin receptor gene polymorphisms and early‐onset prostate cancer
Kote‐Jarai, Z., Singh, R. P., Durocher, F., Easton, D. F., Edwards, S. M., Ardern-Jones, A. T., Dearnaley, D. P., Houlston, R. S., Kirby, R. S., & Eeles, R. A. (2003) · British Journal of Urology · doi:10.1046/j.1464-410x.2003.04272.x · Cited by 29
Irani, J., Lefebvre, O., Murat, F., Dahmani, L., & Dore, B. (2003) · British Journal of Urology · doi:10.1046/j.1464-410x.2003.04133.x · Cited by 29
Joint Effects of Smoking and Body Mass Index on Prostate Cancer Risk
Sharpe, C. R., & Siemiatycki, J. (2001) · Epidemiology · doi:10.1097/00001648-200109000-00014 · Cited by 24
Molecular Interactions of Leptin and Prostate Cancer
Gade‐Andavolu, R., Cone, L. A., Shu, S., Morrow, A. A., Kowshik, B., & Andavolu, M. (2006) · The Cancer Journal · doi:10.1097/00130404-200605000-00008 · Cited by 24
Cited by
Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome
Maury, E., & Brichard, S. M. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.07.031 · Cited by 1,026
Obesity and cancer: the role of dysfunctional adipose tissue
van Kruijsdijk, R. C. M., van der Wall, E., & Visseren, F. L. J. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-09-0372 · Cited by 715
The Role of Adiponectin in Cancer: A Review of Current Evidence
Dalamaga, M., Diakopoulos, K. N., & Mantzoros, C. S. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1015 · Cited by 640
The Role of Adipose Tissue and Adipokines in Obesity-Related Inflammatory Diseases
Balistreri, C. R., Caruso, C., & Candore, G. (2010) · Mediators of Inflammation · doi:10.1155/2010/802078 · Cited by 550
De Nunzio, C., Kramer, G., Marberger, M., Montironi, R., Nelson, W., Schröder, F., Sciarra, A., & Tubaro, A. (2011) · European Urology · doi:10.1016/j.eururo.2011.03.055 · Cited by 454
Metadata
- Authors
- Hsing, A. W., Sakoda, L. C., & Chua, S. C.
- Venue
- The American Journal of Clinical Nutrition
- Publisher
- Elsevier BV
- Published
- 2007-09
- Volume
- 86
- Issue
- 3
- Pages
- 843S-857S
- ISSN
- 0002-9165 (ISSN-L)
- OpenAlex
- W2126071318
- Cited by
- 344
- References
- 76
- FWCI
- 12.68
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.